CELLULE UTILISABLE EN IMMUNOTHERAPIE QUI CONTIENT UN PRODUIT DE RECOMBINAISON DE TYPE ACIDE NUCLEIQUE MODIFIE CODANT POUR UN PRODUIT DU GENE DE LA TUMEUR DE WILMS OU POUR UN FRAGMENT DE CELUI-CI, PROCEDE DE PRODUCTION DE LADITE CELLULE ET DUDIT PRODUIT DE RECOMBINAISON DE TYPE ACIDE NUCLEIQUE
A cell according to the present invention is a cell containing a nucleic acid construct encoding a WT1 gene product or a fragment thereof, wherein the nucleic acid construct contains a region encoding a desired fragment of the WT1 gene product and also contains only AUG as a functional initiation codon. The present invention can provide a cell into which a nucleic acid construct having a significantly improved level of expression of a WT1 gene product or a fragment thereof is introduced.
